Vulnerability Details : CVE-2022-38790
Weave GitOps Enterprise before 0.9.0-rc.5 has a cross-site scripting (XSS) bug allowing a malicious user to inject a javascript: link in the UI. When clicked by a victim user, the script will execute with the victim's permission. The exposure appears in Weave GitOps Enterprise UI via a GitopsCluster dashboard link. An annotation can be added to a GitopsCluster custom resource.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2022-38790
- cpe:2.3:a:weave.works:gitops:*:*:*:*:enterprise:*:*:*
- cpe:2.3:a:weave.works:gitops:0.9.0:rc1:*:*:enterprise:*:*:*
- cpe:2.3:a:weave.works:gitops:0.9.0:rc2:*:*:enterprise:*:*:*
- cpe:2.3:a:weave.works:gitops:0.9.0:rc3:*:*:enterprise:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-38790
0.07%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 30 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-38790
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
2.3
|
2.7
|
NIST |
CWE ids for CVE-2022-38790
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
References for CVE-2022-38790
-
https://docs.gitops.weave.works/security/cve/enterprise/CVE-2022-38790/index.html
Malicious links can be crafted by users and shown in the UI | Weave GitOpsExploit;Patch;Vendor Advisory
-
https://docs.gitops.weave.works/docs/intro
Introduction | Weave GitOpsProduct;Vendor Advisory
-
https://www.weave.works/product/gitops-enterprise/
Weave GitOps Enterprise - GitOps at Scale | WeaveworksProduct;Vendor Advisory
-
https://docs.gitops.weave.works/docs/cluster-management/getting-started/#profiles-and-clusters
Getting started | Weave GitOpsProduct;Vendor Advisory
Jump to